Clinical Trials in Pittsburgh

Showing 12261-12280 of 21,047 trials

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

NCT02253992

The purpose of this study is to determine which doses of Urelumab and Nivolumab are safe and tolerable when they are given together.

Advanced Solid TumorsAdvanced B-cell NHL

Bristol-Myers Squibb232 participantsStarted Sep 2014

Palo Alto, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +14 more locations

COMPLETEDPhase 377 miles

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02940886

Evaluate safety and efficacy of iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®) compared with iron sucrose (Venofer®), in subjects diagnosed with IDA.

Iron Deficiency AnaemiaIron Deficiency Anemia

Pharmacosmos A/S1,512 participantsStarted Nov 2016

Birmingham, Alabama, United States • Dothan, Alabama, United States • Guntersville, Alabama, United States +111 more locations

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Find Trials by Condition in Pittsburgh

Losartan to Reverse Sickle Nephropathy

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

HBP Device EGM Data Collection

SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy